General Clinical Specialties -> Endocrinology/Neuroendocrine 509

509 - Post total thyroidectomy elevated anti-thyroglobulin antibodies in patients with differentiated thyroid cancer - Residual disease or residual thyroiditis? (ID 197)

Session Name
60 - Thyroid and Para-Thyroid
Speakers
Authors
Presentation Topic
General Clinical Specialties -> Endocrinology/Neuroendocrine
Presentation Number
509

Previous Eposter
508 - Potassium iodide therapy may not impair efficacy of radioiodine therapy for Graves’ hyperthyroidism if discontinued 2 weeks before administration of I-131 (ID 194)

Next Eposters
510 - “Thyroid flare” phenomenon on FDG-PET/CT after radiotherapy for extranodal mucosa-associated lympoid tissue lymphoma in the thyroid. (ID 195)
534 - Evaluation of 223Ra therapy on bone metastases of prostate cancer by 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy/SPECT (ID 1271)
540 - Salivary gland toxicity after PRLT using Lu-177 PSMA in patients with advanced prostate cancer: A single-center systematic investigation (ID 1266)
541 - PET imaging of GPC3 expression in hepatocellular carcinoma using new 18F-labeled binding peptides (ID 44)
545 - Comparison of 1-(2-[18F]fluoroethyl)-L-tryptophan and FDG for the detection of medulloblastoma in a transgenic mouse model (ID 50)
546 - Lipophilicity Determines Route of Clearance of a Melanocortin 1 Receptor Targeted Radiopharmaceutical (ID 48)
547 - Develop picomole-affinity VEGFR-PET probe for targeting tumor angiogenesis (ID 51)
557 - FES mean standardized uptake value is a prognostic marker for patients with endometrial carcinoma (ID 759)
587 - 68Ga-PSMA-11 PET/CT detects prostate cancer at early biochemical recurrence with superior detection rate and reader agreement when compared to 18F-Fluciclovine PET/CT in a prospective head-to-head comparative phase 3 study< (ID 1281)
601 - Dedicated Breast PET for Detection of Early Treatment Response in Breast Cancer Patients (ID 560)